Kate Orroth, PhD, MPH

Amgen
Manhattan Beach, CA, United States

Skilled epidemiologist with extensive study design, execution and implementation gained from industry and academic research settings. Expertise includes evidence generation using real world data to support the drug development process. Recognized for leading novel approaches to study design, development and execution with cross-functional teams.

Disclosure information not submitted.

Presentation(s):

• 1187: Obesity Burden and Effects of Apremilast on Changes in Cardiometabolic Parameters by Obesity Status in Patients with Psoriasis (PsO) or Psoriatic Arthritis (PsA) in a Real-World Setting

  Sunday, November 13, 2022
  1:00 PM – 3:00 PM Eastern Time

• 1188: Diabetes Burden and Effects of Apremilast on Changes in Cardiometabolic Parameters in Patients with Psoriasis (PsO) or Psoriatic Arthritis (PsA) in a Real-World Setting

  Sunday, November 13, 2022
  1:00 PM – 3:00 PM Eastern Time